The Paragon Report Provides Stock Research on Arena Pharmaceuticals and VIVUS
Continue ReadingTag: analyst-reports
FDA Considering Allowing Developers of Critical Drugs/Treatments to Conduct Smaller, Faster Clinical Trials
The Paragon Report Provides Stock Research on Achillion Pharmaceuticals and Halozyme Therapeutics
Continue ReadingFDA Considering Faster Approval Process for Developers of Drugs for Deadly or Debilitating Diseases
The Paragon Report Provides Stock Research on Novavax and Cardium Therapeutics
Continue ReadingSmaller, Faster Clinical Trials Considered by the FDA for Developers of Critical Drugs and Treatments
The Paragon Report Provides Stock Research on Ariad Pharmaceuticals and Galena Biopharma
Continue ReadingCollective Third Quarter Profits of the S&P 500 Index Expected to Decline
Five Star Equities Provides Stock Research on Amazon.com and Caterpillar
Continue ReadingCritical Drugs Deemed to Offer Societal Benefit Could See Fast FDA Approval Process
The Paragon Report Provides Stock Research on PDL BioPharma and Sequenom
Continue ReadingMajor Banks Benefitting From Improved Mortgage Profit Margins
The Paragon Report Provides Stock Research on Bank of America and Citigroup
Continue ReadingJames River Coal and Patriot Coal Shares Rally as Metallurgical Coal Demand Speculated to Rise
Five Star Equities Provides Stock Research on James River Coal and Patriot Coal
Continue ReadingBaltic Dry Index Sees Worst Quarter in 14 Years as Oversupply and Low Demand Continues to Plague Industry
Five Star Equities Provides Stock Research on Diana Shipping and Excel Maritime Carriers
Continue ReadingQUALCOMM and SanDisk Look to Benefit From Strong iPhone 5 Demand
Five Star Equities Provides Stock Research on QUALCOMM and SanDisk
Continue Reading